Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004381 · ClinicalTrials.gov registry record · Phase 2
Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
A Phase 2 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00004381 is a Phase 2 study that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
The verdict
NCT00004381, a Phase 2 study, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
OBJECTIVES: I. Compare the efficacy of preventive vs. therapeutic tin mesoporphyrin in direct Coombs' test-positive ABO hemolytic disease of the newborn and glucose-6-phosphate dehydrogenase deficiency in infants living in Greece. II. Assess the safety of tin mesoporphyrin in high-risk newborns.
Interventions
- DRUG tin mesoporphyrin
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-12 |
| Phase | Phase 2 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004381
The ClinicalTrials.gov registry entry for NCT00004381 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tin mesoporphyrin is the first listed.
NCT00004381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004381 about?
NCT00004381 is a clinical study titled "Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia". OBJECTIVES: I. Compare the efficacy of preventive vs. therapeutic tin mesoporphyrin in direct Coombs' test-positive ABO hemolytic disease of the newborn and glucose-6-phosphate dehydrogenase deficiency in infants living in Greece. II. Assess the safety of tin mesoporphyrin in high-risk newborns.
What is the current status of trial NCT00004381?
This trial is currently completed. It is a Phase 2 study. The study started on 1999-12.
What interventions are being tested in trial NCT00004381?
The interventions under investigation include: tin mesoporphyrin (DRUG).
Who is sponsoring clinical trial NCT00004381?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.